Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (352)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
2023
289
5.990
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2022
1404
1.610
Why?
Down Syndrome
5
2019
329
1.600
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
8
2021
57
1.370
Why?
Asparaginase
8
2020
32
1.040
Why?
Burkitt Lymphoma
2
2020
58
0.910
Why?
Consolidation Chemotherapy
2
2019
12
0.820
Why?
Child
63
2023
18649
0.810
Why?
Leukemia, Myeloid, Acute
5
2022
501
0.800
Why?
Leukemia
4
2021
207
0.680
Why?
Child, Preschool
44
2023
9714
0.680
Why?
Mercaptopurine
5
2017
18
0.630
Why?
Oncogene Proteins, Fusion
5
2021
201
0.590
Why?
Disease-Free Survival
10
2022
678
0.570
Why?
Antineoplastic Agents
7
2019
2016
0.560
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
95
0.560
Why?
Preleukemia
1
2015
2
0.560
Why?
Neoplasm Recurrence, Local
3
2021
846
0.550
Why?
Drug Hypersensitivity
3
2017
86
0.540
Why?
Leukemia, Monocytic, Acute
1
2014
4
0.530
Why?
Sarcoma, Myeloid
1
2014
4
0.530
Why?
Molecular Targeted Therapy
3
2021
376
0.520
Why?
Prognosis
13
2021
3549
0.490
Why?
Infant
31
2023
8255
0.470
Why?
Bone Marrow Transplantation
1
2014
271
0.470
Why?
Acute Kidney Injury
1
2019
643
0.460
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
18
0.460
Why?
Neoplasm, Residual
6
2021
93
0.450
Why?
Erwinia
2
2020
3
0.450
Why?
Tumor Suppressor Proteins
3
1999
281
0.440
Why?
Chromosome Aberrations
2
2022
129
0.440
Why?
Neutropenia
2
2022
128
0.430
Why?
Adolescent
36
2023
18902
0.430
Why?
Hematopoietic Stem Cell Transplantation
2
2019
563
0.420
Why?
Stem Cell Transplantation
3
2019
146
0.410
Why?
Humans
75
2023
117633
0.400
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
88
0.400
Why?
Rhabdomyosarcoma
1
2011
56
0.400
Why?
Male
53
2023
60403
0.400
Why?
Sarcoma, Ewing
1
2011
68
0.390
Why?
Cell Cycle Proteins
3
1999
569
0.390
Why?
Ploidies
2
2019
20
0.380
Why?
Carrier Proteins
3
1999
759
0.370
Why?
Recurrence
8
2022
1009
0.370
Why?
Catheter-Related Infections
2
2022
61
0.360
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
26
0.360
Why?
Genes, Tumor Suppressor
2
1999
82
0.350
Why?
Cyclophosphamide
4
2019
236
0.350
Why?
Catheterization, Central Venous
2
2022
91
0.350
Why?
Philadelphia Chromosome
2
2018
15
0.330
Why?
Female
50
2023
63247
0.330
Why?
Survival Rate
7
2021
1807
0.300
Why?
Vincristine
4
2021
106
0.300
Why?
Medication Adherence
3
2017
553
0.300
Why?
Trisomy
2
2021
65
0.300
Why?
Gene Deletion
2
1998
368
0.300
Why?
Antimetabolites, Antineoplastic
2
2017
84
0.290
Why?
Etoposide
2
2019
161
0.290
Why?
Neoplasm Proteins
2
2018
411
0.280
Why?
Anxiety
3
2016
867
0.260
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
73
0.260
Why?
Treatment Outcome
11
2022
9353
0.240
Why?
Young Adult
13
2023
11077
0.240
Why?
Medical Oncology
4
2022
221
0.240
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
53
0.230
Why?
Gene Rearrangement
3
2019
157
0.230
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
2
0.230
Why?
Induction Chemotherapy
2
2019
56
0.230
Why?
Polyethylene Glycols
5
2020
572
0.230
Why?
Central Venous Catheters
1
2022
35
0.220
Why?
Doxorubicin
2
2022
305
0.220
Why?
Lymphoma
1
2023
180
0.220
Why?
Prednisone
2
2019
250
0.210
Why?
Lung Neoplasms
1
2014
2171
0.210
Why?
Program Evaluation
2
2017
870
0.210
Why?
Polymorphism, Single Nucleotide
3
2017
1777
0.200
Why?
Adult
21
2023
32118
0.200
Why?
Translocation, Genetic
2
2013
99
0.200
Why?
Bacterial Infections
1
2022
220
0.200
Why?
Maintenance Chemotherapy
2
2017
25
0.200
Why?
Risk Factors
11
2022
9124
0.190
Why?
Diploidy
1
2019
11
0.190
Why?
Immunocompromised Host
1
2021
210
0.190
Why?
Genes, p16
1
1999
20
0.180
Why?
Antibodies, Bispecific
1
2019
29
0.180
Why?
Prospective Studies
9
2022
6422
0.180
Why?
Hyperglycemia
1
2023
330
0.180
Why?
PAX5 Transcription Factor
1
2019
27
0.180
Why?
Myelodysplastic Syndromes
1
2020
115
0.180
Why?
Chromosomes, Human, Pair 19
1
1998
24
0.180
Why?
Chromosomes, Human, Pair 17
1
1998
48
0.180
Why?
Rituximab
1
2019
171
0.170
Why?
Mutagenesis
1
1999
175
0.170
Why?
Chromosomes, Human, Pair 1
1
1998
66
0.170
Why?
Prostate-Specific Antigen
2
2009
164
0.170
Why?
Substance Withdrawal Syndrome
1
2020
185
0.170
Why?
Patient Safety
1
2021
310
0.160
Why?
Family Relations
2
2016
79
0.160
Why?
Quality of Life
2
2021
2354
0.160
Why?
Oncologists
1
2017
28
0.160
Why?
Proto-Oncogenes
1
1997
28
0.160
Why?
Thionucleotides
1
2017
34
0.160
Why?
Thioguanine
1
2017
21
0.160
Why?
Apyrase
1
2017
14
0.160
Why?
Retrospective Studies
9
2023
12331
0.160
Why?
Blast Crisis
1
2016
19
0.150
Why?
Genomics
2
2022
534
0.150
Why?
Carboxypeptidases A
1
2016
2
0.150
Why?
Follow-Up Studies
6
2021
4911
0.150
Why?
Sepsis
1
2022
491
0.150
Why?
Pediatricians
1
2017
110
0.150
Why?
Depression
2
2016
1196
0.150
Why?
Mentoring
1
2017
89
0.150
Why?
Osteonecrosis
1
2015
20
0.140
Why?
Mentors
2
2017
156
0.140
Why?
Nausea
1
2016
108
0.140
Why?
Central Nervous System Neoplasms
1
2017
126
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
309
0.140
Why?
Adrenal Cortex Hormones
1
2019
517
0.140
Why?
Dexamethasone
4
2021
305
0.140
Why?
Pancreatitis
1
2016
112
0.140
Why?
Longitudinal Studies
7
2016
2668
0.140
Why?
Mutation
4
2022
3409
0.140
Why?
Fusion Proteins, bcr-abl
2
2016
62
0.130
Why?
Bacteremia
1
2016
160
0.130
Why?
Monitoring, Physiologic
1
2017
269
0.130
Why?
High-Throughput Nucleotide Sequencing
1
2017
423
0.130
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.130
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
66
0.130
Why?
Antigens, CD
1
2017
470
0.130
Why?
Cross Infection
1
2016
199
0.130
Why?
Histone-Lysine N-Methyltransferase
2
2010
99
0.130
Why?
Flow Cytometry
1
2018
1132
0.130
Why?
Repressor Proteins
1
1997
398
0.130
Why?
Immunotherapy
1
2018
477
0.130
Why?
Venous Thromboembolism
1
2017
206
0.130
Why?
Life Change Events
1
2014
134
0.120
Why?
Chromosomes, Human, Pair 21
1
2013
29
0.120
Why?
Pediatrics
3
2021
1021
0.120
Why?
Quality Improvement
1
2021
940
0.120
Why?
DNA-Binding Proteins
2
1998
1384
0.120
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
8
0.120
Why?
Self Report
1
2017
715
0.120
Why?
Karyotyping
3
2019
106
0.110
Why?
Myeloproliferative Disorders
1
2012
25
0.110
Why?
Transcription Factors
2
1998
1623
0.110
Why?
Arabinonucleosides
1
2011
9
0.110
Why?
Adenine Nucleotides
1
2011
21
0.110
Why?
Contraindications
1
2012
93
0.110
Why?
Antibodies, Monoclonal
1
2018
1267
0.110
Why?
Cohort Studies
5
2021
5112
0.100
Why?
Prostatic Neoplasms
2
2009
977
0.100
Why?
Chromosomes, Human, Pair 10
1
2010
17
0.100
Why?
Chromosomes, Human, Pair 4
1
2010
33
0.100
Why?
Parents
2
2016
1163
0.100
Why?
T-Lymphocytes
1
2018
1793
0.100
Why?
Pain
1
2016
796
0.090
Why?
Multivariate Analysis
4
2015
1584
0.090
Why?
Bloom Syndrome
1
1988
1
0.090
Why?
Prostatectomy
1
2009
113
0.090
Why?
Age Factors
8
2019
3223
0.090
Why?
Neoplasm Metastasis
1
2011
593
0.090
Why?
Juxtaglomerular Apparatus
1
2007
1
0.080
Why?
Gene Expression Regulation, Leukemic
2
2016
54
0.080
Why?
Polymerase Chain Reaction
1
2010
1016
0.080
Why?
Blood Coagulation
1
2008
200
0.080
Why?
Drug Administration Schedule
2
2017
780
0.070
Why?
Methotrexate
2
2017
243
0.070
Why?
Stress, Psychological
1
2014
1149
0.070
Why?
Remission Induction
2
2019
264
0.070
Why?
Drug Monitoring
2
2017
188
0.070
Why?
Acute Disease
2
2019
983
0.070
Why?
Personal Satisfaction
2
2017
183
0.060
Why?
Administration, Oral
2
2017
786
0.060
Why?
Genetic Variation
1
1988
801
0.060
Why?
Kidney Neoplasms
1
2007
342
0.060
Why?
Randomized Controlled Trials as Topic
2
2020
1209
0.060
Why?
Disease Progression
2
2021
2541
0.060
Why?
Transcriptome
2
2019
731
0.060
Why?
Proto-Oncogene Proteins c-cbl
1
2022
14
0.060
Why?
Incidence
2
2019
2504
0.050
Why?
Exome
1
2022
163
0.050
Why?
Drug Therapy
1
2021
74
0.050
Why?
Diarrhea
2
1999
172
0.050
Why?
Bone Marrow
1
2022
255
0.050
Why?
Risk Assessment
3
2017
3208
0.050
Why?
Endocrine Glands
1
1979
17
0.050
Why?
Genome-Wide Association Study
2
2016
1036
0.050
Why?
Surveys and Questionnaires
3
2017
4842
0.050
Why?
Blood Cell Count
1
1999
58
0.050
Why?
Azacitidine
1
2020
105
0.050
Why?
Viral Load
1
2021
416
0.050
Why?
Chromosomes, Human
1
2019
40
0.050
Why?
Loss of Heterozygosity
1
1999
35
0.050
Why?
Mosaicism
1
2019
55
0.050
Why?
Cytogenetic Analysis
1
2019
29
0.050
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
149
0.050
Why?
Interviews as Topic
1
2021
614
0.050
Why?
Disinfectants
1
1999
28
0.040
Why?
Infant, Newborn
4
2019
5230
0.040
Why?
Chromosomes
1
2019
78
0.040
Why?
Sequence Deletion
1
1999
180
0.040
Why?
National Cancer Institute (U.S.)
1
2018
40
0.040
Why?
United States
4
2021
12768
0.040
Why?
Escherichia coli O157
1
1998
9
0.040
Why?
Hypertension
1
2007
1202
0.040
Why?
Overweight
1
2023
495
0.040
Why?
Methylation
1
1998
216
0.040
Why?
Feasibility Studies
1
2021
766
0.040
Why?
Community Participation
1
1999
120
0.040
Why?
Family
1
2021
567
0.040
Why?
Erythrocyte Count
1
2017
18
0.040
Why?
Glucose
1
2023
926
0.040
Why?
Food-Drug Interactions
1
2017
7
0.040
Why?
Leucovorin
1
2017
47
0.040
Why?
Public Health Surveillance
1
2017
63
0.040
Why?
Biopsy
1
2021
1070
0.040
Why?
Injections, Intramuscular
1
2017
125
0.040
Why?
Water Purification
1
1999
115
0.040
Why?
Genetic Predisposition to Disease
2
2017
2206
0.040
Why?
Career Mobility
1
2017
71
0.040
Why?
Escherichia coli Infections
1
1998
125
0.040
Why?
Proto-Oncogene Proteins c-ets
1
1997
52
0.040
Why?
Qualitative Research
1
2021
856
0.040
Why?
Dairy Products
1
2017
33
0.040
Why?
Cranial Irradiation
1
2017
63
0.040
Why?
Cerebrospinal Fluid
1
2017
93
0.040
Why?
MEF2 Transcription Factors
1
2016
58
0.040
Why?
Sulfonamides
1
2020
451
0.040
Why?
Infusions, Intravenous
1
2017
393
0.040
Why?
Methyltransferases
1
2017
59
0.040
Why?
NIH 3T3 Cells
1
2016
133
0.040
Why?
Leukocyte Count
1
2017
328
0.040
Why?
Luciferases
1
2016
148
0.040
Why?
Methyl Ethers
1
1996
10
0.040
Why?
Anesthetics, Inhalation
1
1996
18
0.040
Why?
Ethers
1
1996
15
0.040
Why?
Breast Neoplasms
5
1979
1929
0.040
Why?
Middle Aged
10
2019
28659
0.040
Why?
Bone Morphogenetic Protein 7
1
2015
10
0.040
Why?
Fluorides
1
1996
49
0.040
Why?
Cytarabine
1
2016
59
0.040
Why?
Health Education
1
1999
342
0.040
Why?
Alternative Splicing
1
2017
201
0.030
Why?
Genotype
3
2017
1825
0.030
Why?
DNA Methylation
1
1999
441
0.030
Why?
Severity of Illness Index
2
2017
2884
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
209
0.030
Why?
Intensive Care Units, Pediatric
1
2016
197
0.030
Why?
Disease Management
1
2019
603
0.030
Why?
Homeodomain Proteins
1
1998
496
0.030
Why?
HEK293 Cells
1
2017
656
0.030
Why?
Biomarkers, Tumor
1
2021
1049
0.030
Why?
Aged
9
2019
20249
0.030
Why?
Sequence Analysis, RNA
1
2016
413
0.030
Why?
Promoter Regions, Genetic
1
1999
1220
0.030
Why?
Algorithms
1
2021
1550
0.030
Why?
Income
1
2014
174
0.030
Why?
Blood Glucose
1
2023
1904
0.030
Why?
Demography
1
2014
279
0.030
Why?
Marriage
1
2014
111
0.030
Why?
Behavior
1
2014
107
0.030
Why?
Psychomotor Agitation
1
2014
79
0.030
Why?
Base Sequence
1
2016
2171
0.030
Why?
In Situ Hybridization, Fluorescence
1
2013
328
0.030
Why?
Clinical Trials as Topic
1
2017
999
0.030
Why?
Case-Control Studies
2
2016
3269
0.030
Why?
Odds Ratio
1
2015
1038
0.030
Why?
Nucleoside Transport Proteins
1
2011
4
0.030
Why?
Aggression
1
2014
204
0.030
Why?
Erythrocytes
1
2017
610
0.030
Why?
Antineoplastic Agents, Alkylating
1
2011
65
0.030
Why?
Regression Analysis
1
2014
1072
0.030
Why?
Escherichia coli
1
2015
789
0.030
Why?
Mice
2
2019
15537
0.030
Why?
Time Factors
2
2015
6906
0.030
Why?
Bacteria
1
2016
671
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
193
0.020
Why?
Survival Analysis
1
2013
1358
0.020
Why?
Logistic Models
1
2015
2018
0.020
Why?
Obesity
1
2023
2711
0.020
Why?
Prevalence
1
2016
2438
0.020
Why?
Emotions
1
2014
473
0.020
Why?
Kaplan-Meier Estimate
1
2011
896
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Mice, Inbred C57BL
1
2019
5136
0.020
Why?
Genetic Complementation Test
1
1988
65
0.020
Why?
Cell Fusion
1
1988
54
0.020
Why?
Protein C
1
2008
38
0.020
Why?
Water Microbiology
2
1999
76
0.020
Why?
Antithrombins
1
2008
58
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
93
0.020
Why?
Fibrinogen
1
2008
161
0.020
Why?
Genetic Markers
1
1988
349
0.020
Why?
Renin-Angiotensin System
1
2007
84
0.020
Why?
Biomarkers
1
2017
3574
0.020
Why?
Biopsy, Needle
1
2007
193
0.020
Why?
Rare Diseases
1
2007
87
0.020
Why?
Transplantation, Homologous
1
2008
464
0.020
Why?
Blood Pressure Determination
1
2007
130
0.020
Why?
Nephrectomy
1
2007
160
0.020
Why?
Animals
2
2019
34350
0.020
Why?
RNA, Messenger
1
2011
2757
0.020
Why?
Immunohistochemistry
1
2007
1756
0.010
Why?
Cell Line
1
1988
2832
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Menstruation
1
1979
34
0.010
Why?
Estrone
1
1979
32
0.010
Why?
Prolactin
1
1979
107
0.010
Why?
Bolivia
1
1999
46
0.010
Why?
Luteinizing Hormone
1
1979
187
0.010
Why?
Follicle Stimulating Hormone
1
1979
220
0.010
Why?
Restaurants
1
1998
14
0.010
Why?
Food Handling
1
1998
23
0.010
Why?
Swimming
1
1998
51
0.010
Why?
Progesterone
1
1979
258
0.010
Why?
Water Supply
1
1998
73
0.010
Why?
Disease Transmission, Infectious
1
1998
61
0.010
Why?
Meat
1
1998
65
0.010
Why?
Estradiol
1
1979
465
0.010
Why?
Halothane
1
1996
6
0.010
Why?
Feces
1
1998
366
0.010
Why?
Population Surveillance
1
1999
449
0.010
Why?
Analysis of Variance
1
1999
1451
0.010
Why?
Ovarian Neoplasms
1
1978
386
0.010
Why?
Risk
4
1978
926
0.010
Why?
Pedigree
3
1978
471
0.010
Why?
Kidney
1
1996
1237
0.010
Why?
Aged, 80 and over
1
1999
6795
0.000
Why?
Nebraska
2
1976
6
0.000
Why?
New York
2
1976
113
0.000
Why?
Genes
1
1978
225
0.000
Why?
Genetic Linkage
1
1978
303
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
5
0.000
Why?
Genetic Techniques
1
1976
62
0.000
Why?
Pheochromocytoma
1
1976
52
0.000
Why?
Klinefelter Syndrome
1
1976
53
0.000
Why?
Syndrome
1
1976
352
0.000
Why?
Pregnancy
2
1978
5554
0.000
Why?
Statistics as Topic
1
1976
333
0.000
Why?
HLA Antigens
1
1976
213
0.000
Why?
Sarcoma
1
1976
131
0.000
Why?
Abnormalities, Multiple
1
1976
177
0.000
Why?
Skin Diseases
1
1976
157
0.000
Why?
Thyroid Neoplasms
1
1976
240
0.000
Why?
Neoplasms
2
1976
2139
0.000
Why?
Sex Factors
1
1978
1918
0.000
Why?
Melanoma
1
1976
703
0.000
Why?
Phenotype
1
1976
2875
0.000
Why?
Brain Neoplasms
1
1976
976
0.000
Why?
Registries
1
1976
1969
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)